VEGFA and ischemia: The findings from our study suggest that ischemia may not be a key predictor for the anti-VEGF therapy requirement in DR; but rather that the leakage index may reflect more current vascular disease activity and may be more indicative of a future need for anti-VEGF therapy, whereas ischemia may be more reflective of overall disease effects and not current disease activity.